Pages

Tuesday, January 28, 2014

Ranbaxy has had so much regulatory action by FDA it has its own FDA page--

Regulatory Action Against Ranbaxy


Consent Decree for Toansa, India, Facility
 
Import Alert and Consent Decree for Mohali, India, Facility
Department of Justice Action Against Ranbaxy
  • DOJ News Release6: Generic Drug Manufacturer Ranbaxy Pleads Guilty and Agrees to Pay $500 Million to Resolve False Claims Allegations, CGMP Violations and False Statements to the FDA (5/13/2013)

Consent Decree for Paonta Sahib, Batamandi, and Dewas, India, Facilities and Ohm Laboratories in Gloversville, N.Y.
  • FDA News Release7: Department of Justice files consent decree of permanent injunction against Ranbaxy (1/25/2012)
 
Application Integrity Policy Action for Paonta Sahib, India, Facility
 
Import Alert for Dewas and Paonta Sahib, India, Facilities

Additional Warning Letters
quoted from here
 

No comments:

Post a Comment